Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

An Intervention to Improve Implantable Cardioverter-Defibrillator Deactivation Conversations (WISDOM)

This study has been completed.
Sponsor:
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI)
University of Colorado, Denver
Mayo Clinic
University of Pennsylvania
Oregon Health and Science University
Montefiore Medical Center
Information provided by (Responsible Party):
Icahn School of Medicine at Mount Sinai
ClinicalTrials.gov Identifier:
NCT01459744
First received: October 13, 2011
Last updated: October 5, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2016
  Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)